SpyGlass Pharma, Inc. (SGP)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Dr. Malik Y. Kahook M.D.
|
Co-Founder, President, Chief Medical Officer & Executive Chairman | 424.23k | -- | 1975 |
|
Mr. Patrick H. Mooney
|
CEO & Director | 659.63k | -- | 1974 |
|
Dr. Chetan Pujara Ph.D.
|
Chief Research & Development Officer | 523.39k | -- | 1970 |
|
Mr. Glenn Sussman
|
Co-founder & Chief Technology Advisor | -- | -- | 1964 |
|
Dr. Jean-Frederic Viret Ph.D.
|
Chief Financial Officer | -- | -- | 1966 |
|
Mr. James Robert Dennewill Jr.
|
Chief Operating Officer | -- | -- | 1981 |
|
Ms. Shannon Trevino J.D.
|
General Counsel | -- | -- | -- |
|
Mr. Mike Pinder
|
Vice President of Marketing | -- | -- | -- |
|
Ms. Rachel Gilette
|
Vice President of Human Resources | -- | -- | -- |
|
Mr. Paul Yoo O.D.
|
Senior Vice President of Clinical Development | -- | -- | -- |
SpyGlass Pharma, Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 76
Description
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.
Corporate Governance
Upcoming Events
November 5, 2026 at 9:00 PM UTC
SpyGlass Pharma, Inc. Earnings Date
